Article
Scoliosis in osteogenesis imperfecta caused by COL1A1/COL1A2 mutations - genotype-phenotype correlations and effect of bisphosphonate treatment.
Bone - 1 May 2016
Sato Atsuko, Ouellet Jean, Muneta Takeshi, Glorieux Francis H, Rauch Frank
Abstract excerpt
Bisphosphonates are widely used to treat children with osteogenesis imperfecta (OI), a bone fragility disorder that is most often caused by mutations in COL1A1 or COL1A2. However, it is unclear whether this treatment decreases the risk of developing scoliosis. We retrospectively evaluated spine radiographs and charts of 437 patients (227 female) with OI caused by mutations in COL1A1 or COL1A2 and compared the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
